The Current Ratio as of November 2024 (TTM) for Omega Therapeutics, Inc. (OMGA) is 1.61

According to Omega Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.61. This represents a change of -35.75% compared to the average of 2.51 of the last 4 quarters.

Omega Therapeutics, Inc. (OMGA) Historical Current Ratio (quarterly & annually)

How has OMGA Current Ratio performed in the past?

The mean historical Current Ratio of Omega Therapeutics, Inc. over the last ten years is 6.49. The current 1.61 Current Ratio has changed 2.38% with respect to the historical average. Over the past ten years (40 quarters), OMGA's Current Ratio was at its highest in in the December 2021 quarter at 19.13. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Omega Therapeutics, Inc. (OMGA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Omega Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Omega Therapeutics, Inc. (OMGA) Average Current Ratio

How has OMGA Current Ratio performed in the past?

The current Current Ratio of Omega Therapeutics, Inc. (OMGA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Omega Therapeutics, Inc. (OMGA) Current Ratio vs. Peers

How is OMGA’s Current Ratio compared to its peers?

Omega Therapeutics, Inc.’s Current Ratio is less than PMV Pharmaceuticals, Inc. (13.98), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (16.66), less than Pharvaris N.V. (19.08), less than PepGen Inc. (8.47), less than Olema Pharmaceuticals, Inc. (7.10), less than Nuvectis Pharma, Inc. (2.74), less than Larimar Therapeutics, Inc. (13.10), less than Centessa Pharmaceuticals plc (21.52), less than Orchestra BioMed Holdings, Inc. (4.23), less than Aerovate Therapeutics, Inc. (8.78), less than Enliven Therapeutics, Inc. (17.44), less than MoonLake Immunotherapeutics (25.51), less than Structure Therapeutics Inc. (27.63), less than Compass Therapeutics, Inc. (40.74), less than Mineralys Therapeutics, Inc. (8.55), less than Cadrenal Therapeutics, Inc. Common Stock (3.69),

Build a custom stock screener for Omega Therapeutics, Inc. (OMGA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omega Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Omega Therapeutics, Inc. (OMGA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Omega Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.